Evaluation of a commercially available enzyme-linked immunosorbent assay (ELISA) for the determination of C-reactive protein in canine serum

Mads Jens Kjelgaard-Hansen; Annemarie Thuri Kristensen; Asger Lundorff Jensen

Evaluation of a commercially available enzyme-linked immunosorbent assay (ELISA) for the determination of C-reactive protein in canine serum

Mads Jens Kjelgaard-Hansen, Annemarie Thuri Kristensen, Asger Lundorff Jensen

58 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Transboundary and Emerging Diseases
Vol/bind	50
Udgave nummer	3
Sider (fra-til)	164-168
Antal sider	5
ISSN	1865-1674
Status	Udgivet - 2003

Citationsformater

Evaluation of a commercially available enzyme-linked immunosorbent assay (ELISA) for the determination of C-reactive protein in canine serum. / Kjelgaard-Hansen, Mads Jens ; Kristensen, Annemarie Thuri ; Jensen, Asger Lundorff.
I: Transboundary and Emerging Diseases, Bind 50, Nr. 3, 2003, s. 164-168.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{73db2c10a1bc11ddb6ae000ea68e967b,

title = "Evaluation of a commercially available enzyme-linked immunosorbent assay (ELISA) for the determination of C-reactive protein in canine serum",

author = "Kjelgaard-Hansen, {Mads Jens} and Kristensen, {Annemarie Thuri} and Jensen, {Asger Lundorff}",

note = "Kode for bibliotekets beholdning: 'modtaget'",

year = "2003",

language = "English",

volume = "50",

pages = "164--168",

journal = "Transboundary and Emerging Diseases",

issn = "1865-1674",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Evaluation of a commercially available enzyme-linked immunosorbent assay (ELISA) for the determination of C-reactive protein in canine serum

AU - Kjelgaard-Hansen, Mads Jens

AU - Kristensen, Annemarie Thuri

AU - Jensen, Asger Lundorff

N1 - Kode for bibliotekets beholdning: 'modtaget'

PY - 2003

Y1 - 2003

M3 - Journal article

SN - 1865-1674

VL - 50

SP - 164

EP - 168

JO - Transboundary and Emerging Diseases

JF - Transboundary and Emerging Diseases

IS - 3

ER -